NasdaqCM:DNTH
NasdaqCM:DNTHBiotechs

Dianthus Therapeutics (DNTH) Is Up 18.7% After Claseprubart Trial Progress Reshapes Its Autoimmune Focus

Dianthus Therapeutics recently attracted fresh attention as investors reacted to progress in its clinical-stage complement therapeutics pipeline, including mid-to-late-stage trials of claseprubart in several autoimmune neuromuscular conditions and an early-stage study of DNTH212 in systemic lupus erythematosus. An interesting angle for investors is how these parallel programs, alongside lead candidate DNTH103, position Dianthus as a focused player in complement-targeted treatments for severe...
NYSE:CNH
NYSE:CNHMachinery

Did CNH’s (CNH) Plant Closure and Tech Pivot Just Reframe Its Capital and Innovation Strategy?

CNH Industrial recently closed its century-old Burlington manufacturing facility, cutting over 200 jobs while retaining around 60 engineering and testing roles and offering support packages to affected workers. At the same time, its Case IH and CASE brands have been pushing into new technologies, from agricultural application drones to electric and compact construction equipment designed to improve efficiency and sustainability. We’ll now examine how the Burlington plant closure, alongside...
NYSE:IDT
NYSE:IDTTelecom

A Look At IDT (IDT) Valuation After Record Earnings And Insider Share Sales

IDT (IDT) is back on investors’ radar after reporting record earnings and Q1 2026 results that exceeded consensus estimates, along with fresh insider selling by senior executives, including the EVP and COO. See our latest analysis for IDT. Despite record results and insider selling catching headlines, recent trading has cooled, with the 30-day share price return of IDT down 7.04% and the year-to-date share price return down 4.45%. However, the 5-year total shareholder return of 230.86%...
NasdaqCM:VELO
NasdaqCM:VELOMachinery

Assessing Velo3D (VELO) Valuation After New U.S. Army DEVCOM GVSC Supply Chain Agreement

Velo3D (VELO) stock is in focus after the company signed a Cooperative Research & Development Agreement with the U.S. Army DEVCOM GVSC to develop additively manufactured parts for ground combat vehicles. See our latest analysis for Velo3D. The agreement with the U.S. Army arrives after a sharp reset in sentiment, with a 1-day share price return of -16.76% and a 7-day share price return of -30.39% following a very large 90-day gain of 159.04%. However, the 1-year total shareholder return of...
NYSE:VSH
NYSE:VSHElectronic

A Look At Vishay Intertechnology (VSH) Valuation After New Power Electronics Module Launch

Vishay Intertechnology (VSH) has just rolled out four new 100 V Gen 2 Trench MOS Barrier Schottky rectifier modules, a product launch that puts fresh attention on its role in industrial and automotive power electronics. See our latest analysis for Vishay Intertechnology. The new rectifier launch lands after a strong 30-day share price return of 22.92% and a 20.67% year to date share price gain, even though the 3 year total shareholder return is negative at 12.94%. This suggests recent...
NasdaqGS:GLNG
NasdaqGS:GLNGOil and Gas

A Look At Golar LNG (GLNG) Valuation As Long Term FLNG Contracts Support Cash Flow Outlook

Golar LNG (GLNG) has been drawing attention after recent trading that left the stock around US$40. With its focus on floating liquefied natural gas infrastructure, investors are revisiting how current returns align with the underlying business. See our latest analysis for Golar LNG. The recent move toward US$40.46 comes after a 9.22% 1 month share price return and a modest 6.61% year to date share price gain. The 5 year total shareholder return of 306.08% points to a much stronger long...
NYSE:CPA
NYSE:CPAAirlines

How Investors May Respond To Copa Holdings (CPA) Stronger December Load Factor And Traffic Gains

Copa Holdings, S.A. recently reported its December 2025 preliminary traffic results, with capacity (ASM) and traffic (RPM) each rising around 10% year over year and load factor improving to 86.0%. The simultaneous expansion in capacity and stronger passenger utilization suggests Copa was able to fill a higher proportion of its growing seat inventory during the month. Next, we will examine how this improved load factor shapes Copa Holdings’ investment narrative and what it may signal for...
NasdaqCM:NN
NasdaqCM:NNSoftware

NextNav (NN) Is Up 8.8% After Showcasing FCC-Backed GPS-Backup Vision At Oppenheimer Conference

NextNav Inc. recently announced that Chief Financial Officer Tim Gray participated in the virtual Oppenheimer 11th Annual Emerging Growth Conference held in early February 2026, highlighting the company’s focus on next-generation terrestrial Positioning, Navigation, and Timing and 3D geolocation solutions. This visibility comes as investors closely watch NextNav’s efforts to build an FCC-driven terrestrial GPS-backup network using licensed low-band spectrum and the global 5G ecosystem, a...
NYSE:IVZ
NYSE:IVZCapital Markets

Assessing Invesco (IVZ) Valuation After RBC Upgrade And Upbeat Earnings Outlook

Invesco (IVZ) has drawn fresh attention after a recent RBC Capital upgrade and a series of upward earnings estimate revisions, as analysts point to organic growth, margin improvement and assets under management momentum. See our latest analysis for Invesco. The recent RBC upgrade and earnings optimism come after a strong 90-day share price return of 18.53% and a 1-year total shareholder return of 67.08%. This suggests momentum has been building rather than fading, despite a softer 7-day share...
NYSE:FET
NYSE:FETEnergy Services

A Look At Forum Energy Technologies (FET) Valuation As Offshore And Subsea Sentiment Drives Fresh Volatility

Forum Energy Technologies (FET) is back on many investors’ screens as offshore and subsea spending plans, project pipelines, and pricing discipline come under fresh scrutiny, adding volatility to trading in smaller energy technology names. See our latest analysis for Forum Energy Technologies. At a share price of $43.62, Forum Energy Technologies has seen short term momentum build, with a 30 day share price return of 18.69% and a 90 day share price return of 38.04%. The 1 year total...
NYSE:RDDT
NYSE:RDDTInteractive Media and Services

Reddit Taps Emplifi And Invoca To Deepen Enterprise Marketing Role

Reddit (NYSE:RDDT) has entered a new collaboration with Emplifi to connect its community driven data with Emplifi’s customer experience tools. Reddit has expanded Reddit Ads functionality through Invoca, aiming to give brands clearer attribution and call analytics tied to Reddit ad campaigns. These integrations are part of Reddit’s push to serve enterprise clients that want measurable engagement and insight from Reddit’s communities. For investors watching NYSE:RDDT, these moves illustrate...
NYSE:CNR
NYSE:CNROil and Gas

Assessing Core Natural Resources (CNR) Valuation After EBITDA Beat And Key Mine Restarts

EBITDA beat and mining restarts put Core Natural Resources in focus Core Natural Resources (CNR) is back on investors’ radar after reporting third quarter adjusted EBITDA of $141 million, resuming longwall mining at Leer South and clearing safety issues at Mountaineer II. See our latest analysis for Core Natural Resources. The stock has eased back from a fresh 52 week high of US$102.99 to around US$99. A 12% 1 month share price return and 23.5% 3 month share price return sit alongside a 3...
NYSE:AVA
NYSE:AVAIntegrated Utilities

A Look At Avista (AVA) Valuation As Shares Trade Near Analysts’ Fair Value Estimates

Why Avista Stock Is On Investors’ Radar Avista (AVA) is drawing attention after recent share price moves, with a 1 day return of about a 1.3% decline, in contrast with gains over the past month and past 3 months. See our latest analysis for Avista. At the current share price of US$40.04, Avista’s recent 4.05% 30 day share price return and 3.41% year to date share price return contrast with a stronger 14.27% 1 year total shareholder return, suggesting steady but not accelerating momentum. If...
NasdaqGS:LGIH
NasdaqGS:LGIHConsumer Durables

Assessing LGI Homes (LGIH) Valuation After Recent Share Price Weakness And Mixed Return Profile

How LGI Homes Stock Has Been Moving LGI Homes (LGIH) has recently seen mixed share performance, with a 3.2% decline over the past day and a 4.8% decline over the past week, alongside a gain over the past month. Over the past 3 months the stock has recorded a gain, while the year-to-date figure is also positive. In contrast, the past year, 3-year, and 5-year total returns all show declines. See our latest analysis for LGI Homes. At a share price of $51.21, LGI Homes has seen short term...
NYSE:ZIM
NYSE:ZIMShipping

Sharp Drop In Short Interest Might Change The Case For Investing In ZIM Integrated Shipping (ZIM)

Recently, ZIM Integrated Shipping Services reported that its short interest as a percentage of float fell by 14.99%, to 15.54%, still well above the peer group average of 2.71%. This pullback in short positioning, while remaining elevated versus peers, highlights a shift in sentiment that could be especially important for such a heavily shorted stock. We will now examine how this sharp reduction in short interest shapes ZIM Integrated Shipping Services’ investment narrative and investor...
NasdaqGS:PLTR
NasdaqGS:PLTRSoftware

Palantir Deepens Commercial Roots With HD Hyundai And Sovereign AI Push

Palantir Technologies (NasdaqGS:PLTR) has entered a large, multi-year commercial partnership with South Korea's HD Hyundai, covering shipbuilding, construction, robotics, and electric systems. The agreement places Palantir's AI platforms at the center of HD Hyundai's group-wide digital transformation plans. Separately, Palantir is working on sovereign-grade AI data centers across Europe, the Middle East, and Africa for commercial and government use. Palantir, known for its data and AI...
NasdaqGS:REGN
NasdaqGS:REGNBiotechs

Regeneron Pharmaceuticals (REGN) Valuation Check After Eylea HD Approval And Ongoing Dupixent Momentum

Regeneron Pharmaceuticals (REGN) is back in focus after the approval of its high dose Eylea HD, which cuts injection frequency, combined with continued Dupixent momentum and fresh bullish commentary from analysts and long term shareholders. See our latest analysis for Regeneron Pharmaceuticals. Those Eylea HD and Dupixent updates arrive as Regeneron’s 90 day share price return of 15.14% contrasts with a softer year to date share price return of a 2.93% decline, while the 1 year total...
NasdaqGS:ARWR
NasdaqGS:ARWRBiotechs

Arrowhead Pharmaceuticals (ARWR) Valuation Check After Redemplo’s Third Regulatory Approval And Optimistic Pipeline Outlook

Arrowhead Pharmaceuticals (ARWR) has drawn fresh attention after China’s NMPA approved its drug Redemplo for familial chylomicronemia syndrome. This marks the therapy’s third clearance, following earlier approvals in the US and Canada. See our latest analysis for Arrowhead Pharmaceuticals. At a share price of US$67.05, Arrowhead has given investors a 69.53% 90 day share price return. The 1 year total shareholder return of 231.11% and 3 year total shareholder return of 101.47% underline how...